Abhijeet Jakate

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 11

Top Topics

Squamous Cell Carcinoma

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Michael R Hodges, Susan Hazel, William G Kramer, Ewoud-Jan van Hoogdalem, Sjoerd van Marle, Margaret Tawadrous, Abhijeet Jakate
Pharmacokinetics, safety, and tolerability of fosmanogepix IV to oral switch and multiple IV doses in healthy participants. Antimicrobial agents and chemotherapy 68 (5) (2024)
Michael R Hodges, Susan Hazel, William G Kramer, Ewoud-Jan van Hoogdalem, Sjoerd van Marle, Margaret Tawadrous, Abhijeet Jakate
Pharmacokinetics, safety, and tolerability of fosmanogepix IV to oral switch and multiple IV doses in healthy participants. Antimicrobial agents and chemotherapy 68 (5) (2024)
Michael R Hodges, Susan Hazel, William G Kramer, Ewoud-Jan van Hoogdalem, Sjoerd van Marle, Margaret Tawadrous, Abhijeet Jakate
Pharmacokinetics, safety, and tolerability of fosmanogepix IV to oral switch and multiple IV doses in healthy participants. Antimicrobial agents and chemotherapy 68 (5) (2024)
Michael R Hodges, Susan Hazel, William G Kramer, Ewoud-Jan van Hoogdalem, Sjoerd van Marle, Margaret Tawadrous, Abhijeet Jakate
Pharmacokinetics, safety, and tolerability of fosmanogepix IV to oral switch and multiple IV doses in healthy participants. Antimicrobial agents and chemotherapy 68 (5) (2024)
Michael R Hodges, Eric Ople, Philip Evans, A J Andre Pantophlet, Jessica Richardson, Dylan Williams, Sakambari Tripathy, Margaret Tawadrous, Abhijeet Jakate
A phase 1 open label study to assess the human mass balance and metabolite profile of 14 C-fosmanogepix, a novel Gwt-1 inhibitor in healthy male participants. Antimicrobial agents and chemotherapy (2024)
Michael R Hodges, Eric Ople, Philip Evans, A J Andre Pantophlet, Jessica Richardson, Dylan Williams, Sakambari Tripathy, Margaret Tawadrous, Abhijeet Jakate
A phase 1 open label study to assess the human mass balance and metabolite profile of 14 C-fosmanogepix, a novel Gwt-1 inhibitor in healthy male participants. Antimicrobial agents and chemotherapy 68 (8) (2024)
Michael R Hodges, Susan Hazel, William G Kramer, Ewoud-Jan van Hoogdalem, Sjoerd van Marle, Margaret Tawadrous, Abhijeet Jakate
Pharmacokinetics, safety, and tolerability of fosmanogepix IV to oral switch and multiple IV doses in healthy participants. Antimicrobial agents and chemotherapy (2024)
Michael R Hodges, Sjoerd van Marle, William G Kramer, Eric Ople, Margaret Tawadrous, Abhijeet Jakate
Phase 1 drug-drug interaction study to assess the effect of CYP3A4 inhibition and pan-CYP induction on the pharmacokinetics and safety of fosmanogepix in healthy participants. Antimicrobial agents and chemotherapy (2024)
Michael R Hodges, Eric Ople, Philip Evans, A J Andre Pantophlet, Jessica Richardson, Dylan Williams, Sakambari Tripathy, Margaret Tawadrous, Abhijeet Jakate
A phase 1 open label study to assess the human mass balance and metabolite profile of 14 C-fosmanogepix, a novel Gwt-1 inhibitor in healthy male participants. Antimicrobial agents and chemotherapy 68 (8) (2024)
Michael R Hodges, Eric Ople, Philip Evans, A J Andre Pantophlet, Jessica Richardson, Dylan Williams, Sakambari Tripathy, Margaret Tawadrous, Abhijeet Jakate
A phase 1 open label study to assess the human mass balance and metabolite profile of 14 C-fosmanogepix, a novel Gwt-1 inhibitor in healthy male participants. Antimicrobial agents and chemotherapy 68 (8) (2024)
Michael R Hodges, Susan Hazel, William G Kramer, Ewoud-Jan van Hoogdalem, Sjoerd van Marle, Margaret Tawadrous, Abhijeet Jakate
Pharmacokinetics, safety, and tolerability of fosmanogepix IV to oral switch and multiple IV doses in healthy participants. Antimicrobial agents and chemotherapy (2024)